Collective Molecular Activities of the Plant: Dalbergia Melanoxylon
Example Image
PLANiTS DNA barcode
Taxonomic Information
Plant ID: NPO7149
Plant Latin Name: Dalbergia Melanoxylon
Taxonomy Genus: Dalbergia
Taxonomy Family: Fabaceae
Plant External Links:
NCBI TaxonomyDB:
114981
Plant-of-the-World-Online:
n.a.
Geographical Distribution
See the Plant Occurrence Worldwide with Latitude and Longitude Available
Compounds Summary
Overview of Ingredients
17 All known Ingredients in Total
Unique ingredients have been isolated from this plant.Plant-Ingredients Associations were manually curated from publications or collected from other databases.
17 Ingredients with Acceptable Bioavailablity
Unique ingredients exhibit acceptable human oral bioavailablity, according to the criteria of SwissADME [PMID: 28256516] and HobPre [PMID: 34991690]. The criteria details:SwissADME: six descriptors are used by SwissADME to evaluate the oral bioavailability of a natural product:
☑ LIPO(Lipophility): -0.7 < XLOGP3 < +5.0
☑ SIZE: 150g/mol < MW < 500g/mol
☑ POLAR(Polarity): 20Ų < TPSA < 130Ų
☑ INSOLU(Insolubility): -6 < Log S (ESOL) < 0
☑ INSATU(Insaturation): 0.25 < Fraction Csp3 < 1
☑ FLEX(Flexibility): 0 < Num. rotatable bonds < 9
If 6 descriptors of a natural plant satisfy the above rules, it will be labeled high HOB.
HobPre: A natural plant ingredient with HobPre score >0.5 is labeled high human oral availability (HOB)
7 Ingredients with experimental-derived Activity
Unique ingredients have activity data available.Ingredient Structrual Cards
Ingredient ID: NPC91492
Ingredient ID: NPC86963
Ingredient ID: NPC7785
Ingredient ID: NPC44642
Ingredient ID: NPC3906
Ingredient ID: NPC308694
Ingredient ID: NPC301939
Ingredient ID: NPC287511
Ingredient ID: NPC256555
Ingredient ID: NPC235269
Ingredient ID: NPC226941
Ingredient ID: NPC218575
Ingredient ID: NPC20091
Ingredient ID: NPC197857
Ingredient ID: NPC158170
Ingredient ID: NPC146919
Ingredient ID: NPC108957
Classification of Human Proteins Collectively Targeted by the Plant
*The classification criteria of Drug Transporter (DTP), CYP450 are referred to DrugMap. Other molecular targets in CMAUP are classified as therapeutic targets.
.
Detailed Information of Target Proteins
| Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
|---|---|---|---|---|---|
| Cytochrome P450 | Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
| Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
| Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
| Drug Transporter | SLC superfamily of solute carriers | SLC22A3 | Solute carrier family 22 member 3 | O75751 | CHEMBL2073673 |
| Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
| Therapeutic Target | Transcription factor | PAX8 | Paired box protein Pax-8 | Q06710 | CHEMBL2362980 |
| Therapeutic Target | Transcription factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
| Therapeutic Target | Unclassified protein | GMNN | Geminin | O75496 | CHEMBL1293278 |
Clinical Trials Summary
Overview
Clinical trials associated with plant from natural product (NP) & plant level:
| Clinical trials type | Number of clinical trials | |
|---|---|---|
 NP level | 84 | |
Clinical trial details
| NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
|---|---|---|---|---|
| NCT05503225 | Colchicine Use in Intracranial Atherosclerotic Disease | atherosclerosis | Colchicine (NPC226941) | NP level |
| NCT02162303 | Colchicine in Vascular Inflammation Assessed With PET Imaging | vascular disease | Colchicine (NPC226941) | NP level |
| NCT04516941 | CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 | COVID-19;severe acute respiratory syndrome | Colchicine (NPC226941) | NP level |
| NCT04350320 | Trial to Study the Benefit of Colchicine in Patients With COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT02582190 | COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF | atrial fibrillation | Colchicine (NPC226941) | NP level |
| NCT04867226 | Effectiveness of Colchicine Among Patients With COVID-19 Infection | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT04367168 | Colchicine in Patients With Mild and Severe Coronavirus Disease | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT03131583 | The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout | gout | Colchicine (NPC226941) | NP level |
| NCT03021343 | Effect of Colchicine on the Incidence of Atrial Fibrillation in Open Heart Surgery Patients | cardiac arrhythmia | Colchicine (NPC226941) | NP level |
| NCT01994226 | Colchicine Or Naproxen Treatment for ACute gouT | gout | Colchicine (NPC226941) | NP level |
| NCT04392141 | Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT02176460 | Colchicine for Symptom and Inflammation in Knee Osteoarthritis | osteoarthritis | Colchicine (NPC226941) | NP level |
| NCT01075906 | Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients | familial Mediterranean fever | Colchicine (NPC226941) | NP level |
| NCT04416334 | PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT00819585 | A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study) | gout | Colchicine (NPC226941) | NP level |
| NCT02602028 | The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF | familial Mediterranean fever | Colchicine (NPC226941) | NP level |
| NCT04420624 | COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction | myocardial infarction | Colchicine (NPC226941) | NP level |
| NCT04363437 | COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT01399008 | Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients | gout | Colchicine (NPC226941) | NP level |
| NCT05279690 | Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors | neoplasm;urogenital neoplasm | Colchicine (NPC226941) | NP level |
| NCT00128427 | Study of Colchicine to Prevent the Postpericardiotomy Syndrome | Postpericardiotomy Syndrome | Colchicine (NPC226941) | NP level |
| NCT04539873 | Impact of Colchicine in Hospitalized Colombian Patients With COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT04472611 | Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT00370760 | Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR) | proliferative vitreoretinopathy | Colchicine (NPC226941) | NP level |
| NCT05324423 | To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout | gout | Colchicine (NPC226941) | NP level |
| NCT00723268 | Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae | aphthous ulcer | Colchicine (NPC226941) | NP level |
| NCT04322682 | Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT05159219 | Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage | intracranial hemorrhage | Colchicine (NPC226941) | NP level |
| NCT00506883 | MPC-004 for the Treatment of an Acute Gout Flare | gout | Colchicine (NPC226941) | NP level |
| NCT05472337 | Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome | acute coronary syndrome | Colchicine (NPC226941) | NP level |
| NCT04264260 | Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment | cholangiocarcinoma | Colchicine (NPC226941) | NP level |
| NCT04160117 | Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot) | atrial fibrillation | Colchicine (NPC226941) | NP level |
| NCT02500641 | Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout | gout | Colchicine (NPC226941) | NP level |
| NCT04603690 | Oral Curcumin, Quercetin and Vitamin D3 Supplements for Mild to Moderate Symptoms of COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT02063997 | Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients | gout | Colchicine (NPC226941) | NP level |
| NCT03156816 | COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction | myocardial infarction | Colchicine (NPC226941) | NP level |
| NCT04355143 | Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT04375202 | Colchicine in COVID-19: a Pilot Study | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT05175274 | Colchicine Use for Primary Prevention of Coronary Artery Disease | coronary artery disease | Colchicine (NPC226941) | NP level |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | severe acute respiratory syndrome | Colchicine (NPC226941) | NP level |
| NCT04762771 | Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19) | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT05250596 | COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS) | acute coronary syndrome | Colchicine (NPC226941) | NP level |
| NCT03693781 | Colchicine for Amyotrophic Lateral Sclerosis | amyotrophic lateral sclerosis | Colchicine (NPC226941) | NP level |
| NCT04916522 | The COlchicine HypERtENsion Trial | hypertension | Colchicine (NPC226941) | NP level |
| NCT00004368 | Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis | cirrhosis of liver | Colchicine (NPC226941) | NP level |
| NCT04326790 | The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT04500665 | Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine | chronic kidney disease | Colchicine (NPC226941) | NP level |
| NCT03048825 | Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry | Non-ST Elevation Myocardial Infarction;ST Elevation Myocardial Infarction | Colchicine (NPC226941) | NP level |
| NCT04870424 | Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement | atrial fibrillation | Colchicine (NPC226941) | NP level |
| NCT04328480 | The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT02366091 | Inflammation and Coronary Endothelial Function | coronary artery disease | Colchicine (NPC226941) | NP level |
| NCT00128414 | Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode) | pericarditis | Colchicine (NPC226941) | NP level |
| NCT04492358 | Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT02442921 | Colchicine for Diabetic Nephropathy Trial | diabetic nephropathy | Colchicine (NPC226941) | NP level |
| NCT04724629 | Survival TRial Using CytoKines in COVID-19 (STRUCK Trial) | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT00000577 | Asthma Clinical Research Network (ACRN) | asthma;lung disease | Colchicine (NPC226941) | NP level |
| NCT04322565 | Colchicine Counteracting Inflammation in COVID-19 Pneumonia | coronavirus infectious disease;viral pneumonia | Colchicine (NPC226941) | NP level |
| NCT02330796 | Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout | gout | Colchicine (NPC226941) | NP level |
| NCT04667780 | Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT04008316 | Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis | vasculitis | Colchicine (NPC226941) | NP level |
| NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | COVID-19;severe acute respiratory syndrome | Colchicine (NPC226941) | NP level |
| NCT04360980 | The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT00840489 | Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis | chronic hepatitis C virus infection | Colchicine (NPC226941) | NP level |
| NCT00754819 | Targeting Inflammation in Acute Coronary Syndrome Using Colchicine | acute coronary syndrome | Colchicine (NPC226941) | NP level |
| NCT04997551 | Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19 | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT04130204 | Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS) | gout | Colchicine (NPC226941) | NP level |
| NCT00004748 | Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis | primary biliary cirrhosis | Colchicine (NPC226941) | NP level |
| NCT01985425 | Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study | atrial fibrillation | Colchicine (NPC226941) | NP level |
| NCT05459974 | Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation | atrial fibrillation | Colchicine (NPC226941) | NP level |
| NCT03905759 | Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG | atrial fibrillation | Colchicine (NPC226941) | NP level |
| NCT03015831 | Effect of Low Dose ColchiciNe on the InciDence of POAF | atrial fibrillation | Colchicine (NPC226941) | NP level |
| NCT01481233 | Oral Colchicine in Men With Castrate Resistant Prostate Cancer | prostate cancer | Colchicine (NPC226941) | NP level |
| NCT05118737 | Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia. | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT01005121 | Colchicine for Diabetic Nephropathy | diabetic nephropathy | Colchicine (NPC226941) | NP level |
| NCT04359095 | Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT00128453 | Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences | pericarditis | Colchicine (NPC226941) | NP level |
| NCT01755949 | Colchicine and CRP in Atrial Fibrillation and AF Ablation | atrial fibrillation | Colchicine (NPC226941) | NP level |
| NCT04705987 | Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure | heart failure | Colchicine (NPC226941) | NP level |
| NCT00700297 | Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease | Behcet's syndrome | Colchicine (NPC226941) | NP level |
| NCT03575572 | Colchicine in Postoperative Fontan Patients | heart disease | Colchicine (NPC226941) | NP level |
| NCT05151614 | Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT04756128 | Impact of Colchicine and Low-dose Naltrexone on COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
| NCT02060552 | Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels | gout | Colchicine (NPC226941) | NP level |
| NCT02139046 | Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout | gout | Colchicine (NPC226941) | NP level |
❱❱❱ Associated Human Diseases and Detailed Association Evidence
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
|---|---|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT05459974,NCT03015831,NCT01985425,NCT01755949,NCT04160117,NCT02582190,NCT03905759,NCT04870424
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
THPO,TUBB6,GMNN,TSHR,LMNA,PAX8,SLC22A3
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
TUBB6,HIF1A,GMNN,PAX8,LMNA
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
TUBB6,HIF1A,LMNA,PAX8,SLC22A3
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
GMNN,LMNA,PAX8,SLC22A3
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
GMNN,THPO,TSHR,CYP2D6
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
TUBB6,GMNN,TSHR,LMNA
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
THPO
NCT03156816,NCT04420624 |
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04381936,NCT04324463,NCT04516941
|
Acute ischaemic heart disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA4Z |
NCT05472337,NCT05250596,NCT00754819
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
GMNN,PAX8,TSHR
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
GMNN,PAX8,GMNN
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04516941,NCT04762771,NCT04322682,NCT04367168,NCT04324463,NCT04392141,NCT04756128,NCT04539873,NCT04416334,NCT04867226,NCT05151614,NCT04472611,NCT04355143,NCT04326790,NCT04492358,NCT04359095,NCT04997551,NCT04363437,NCT04328480,NCT04350320,NCT04724629,NCT04667780,NCT04375202,NCT04360980,NCT04603690,NCT05118737
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
HIF1A
NCT04916522 |
Familial Mediterranean feverDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A60.0 |
NCT02602028,NCT01075906
|
Chronic kidney disease, stage unspecifiedDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61.Z |
NCT02442921,NCT01005121
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT05175274,NCT02366091
|
Acute pericarditisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB20 |
NCT00128453,NCT00128414
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
GMNN,TSHR
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
GMNN,TSHR
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
TUBB6,LMNA
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
PAX8,CYP2D6
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
LMNA,HIF1A
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
GMNN,HIF1A
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
TUBB6,THPO
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
NCT02063997,NCT02500641,NCT01399008,NCT02330796,NCT00506883,NCT02139046,NCT00819585,NCT03131583,NCT01994226,NCT02060552,NCT04130204,NCT05324423
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
HIF1A
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
HIF1A
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CYP2D6
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
THPO
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
CYP2D6
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
HIF1A
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
HIF1A
|
Behçet diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A62 |
NCT00700297
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
NCT00004368
|
Oral aphthae or aphtha-like ulcerationDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01.10 |
NCT00723268
|
Cardiac arrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC9Z |
NCT03021343
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
NCT04705987
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
NCT00000577
|
CholangiocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7M15 |
NCT04264260
|
VitreoretinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B78 |
NCT00370760
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NCT04500665
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
NCT04322565
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT00840489
|
Acute ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.0 |
NCT03048825
|
Postcardiotomy syndromeDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE10 |
NCT00128427
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT00000577
|
Primary biliary cholangitis, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.1Z |
NCT00004748
|
VasculitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44 |
NCT04008316
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT05279690
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
NCT03575572
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT02176460
|
Urogenital cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C95-2C9Z |
NCT05279690
|
Viral pneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.1 |
NCT04322565
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT03693781
|
Diseases of the circulatory system, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE2Z |
NCT02162303
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT01481233
|
Intracranial injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07 |
NCT05159219
|
Acute non-ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.1 |
NCT03048825
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT05503225
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
GMNN
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
TSHR
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
SLC22A3
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
TSHR
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
PAX8
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
THPO
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
GMNN
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
THPO
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
GMNN
|
❱❱❱ Network Visualization of Plant-Targeted Human Disease Associations
Plant-Targeted Human Disease Network
>> Targets derived from weak experimental activities
